Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Meiotic recombination protein REC8 homolog (REC8) is a meiosis-specific component of the cohesin complex, encoded by the human REC8 gene. It binds sister chromatids and is essential for their cohesion during both divisions of meiosis[1]. REC8 localizes to chromosome axes during meiosis, forming structural scaffolds necessary for the synaptonemal complex and proper homologous recombination[3]. Its removal from chromosome arms in meiosis I enables homologous chromosomes to separate, while retention at centromeres maintains sister chromatid cohesion until anaphase II[1]. REC8 partners with other cohesin proteins (STAG3, SMC1B, SMC3) to regulate chromatid cohesion and recombination. Disruption leads to improper chromosome pairing, meiotic errors, and sterility[3]. REC8 is not a therapeutic target (such as a receptor, enzyme, or transporter), but is fundamental for meiotic chromosome dynamics and fertility[1][3][4].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meiotic recombination protein REC8 homolog (REC8).